Kelyniam Global, Inc.
Kelyniam Global, Inc.
Your view on KLYG
Overview
What the company does, where it operates, and who runs it.
About Kelyniam Global, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Ross Bjella
- Headquarters
- 97 River Road, Collinsville, CT, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Ross Bjella
- Headquarters
- 97 River Road, Collinsville, CT, US
Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers.
The company develops, manufactures, and distributes custom cranial and craniofacial fixation screws for patients requiring the reconstruction of cranial and facial structures. It serves health systems, hospitals, sales representative, and surgeons, payors, and patients.
The company was formerly known as Ketner Global Investments, Inc. and changed its name to Kelyniam Global, Inc. in December 2007. The company was incorporated in 2005 and is based in Collinsville, Connecticut.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Kelyniam Global, Inc., and the rating behind it. KLYG last traded at $0.10; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Kelyniam Global, Inc.. Starting points for Kelyniam Global, Inc.: beta 0.45 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Kelyniam Global, Inc.. Kelyniam Global, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Kelyniam Global, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Kelyniam Global, Inc.. Kelyniam Global, Inc. has reported as a listed company since 2008. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Kelyniam Global, Inc. valued side by side against its closest peers. Kelyniam Global, Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Kelyniam Global, Inc., and how their positions are changing. At a $1.3M market value, institutional positions materially move Kelyniam Global, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Kelyniam Global, Inc. executives and directors. Shares of Kelyniam Global, Inc. have traded between $0.05 and $0.32 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Kelyniam Global, Inc.. Kelyniam Global, Inc. is a $1.3M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Kelyniam Global, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Kelyniam Global, Inc.. Coverage tracks Kelyniam Global, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.